Updated COVID-19 Booster Vaccines Coming Soon
The Texas Department of State Health Services (DSHS) announced Sept. 2 that doses of the updated COVID-19 booster vaccine are expected to begin arriving at health care providers next week.
Read moreThe Texas Department of State Health Services (DSHS) announced Sept. 2 that doses of the updated COVID-19 booster vaccine are expected to begin arriving at health care providers next week.
Read moreNovavax Friday announced its COVID-19 vaccine was authorized for emergency use by the U.S. Food and Drug Administration for adolescents between 12 and 17.
Read moreInfants and toddlers can receive both the Pfizer and Moderna vaccine as of Friday.
Read moreChildren under 5 may be able to get their first COVID-19 vaccine dose as soon as June 21, if federal regulators approve the shots for that age group as expected.
Read moreThe Centers for Disease Control and Prevention (CDC) Thursday recommended children ages five through 11 receive COVID-19 vaccine booster shots.
Read moreDallas ISD announced Thursday it will partner with several organizations to provide a series of vaccine clinics at various elementary schools later this month.
(Read time: 3.1 minutes)
The Centers for Disease Control and Prevention advisory committee Tuesday unanimously recommended the COVID-19 vaccine created by Pfizer and BioNTech for children ages 5-11.
(Read time: 3.2 minutes)
Last week, a study showed child-sized doses of the Pfizer BioNTech COVID-19 vaccine are 91% effective at preventing symptomatic infection in 5-to-11-year-olds, and the Centers for Disease Control and Prevention (CDC) OK’d booster shots for more people.
(Read time: 2.9 minutes)
Last week, Gov. Greg Abbott issued another executive order cracking down on COVID-19 vaccine mandates, banning any entity in Texas, including private businesses, from requiring vaccinations for employees or customers.
(Read time: 4.1 minutes)
More than 3,600 Texas seniors may have had their lives saved by getting vaccinated against COVID-19, a new federal study indicates.
(Read time: 3.9 minutes)
Not quite three weeks after Pfizer and BioNTech announced that their pediatric two-dose COVID-19 vaccine regimen for children ages 5-11 had been demonstrated to be safe in clinical trials, the companies said they have now submitted a request with the FDA for emergency use authorization.
(Read time: 4.1 minutes)